Tagomics Publishes a new Approach to Genome-Wide Epigenomic Profiling

Study published in 'Cell Reports Methods' demonstrates the strength of Tagomics' platform for epigenomic biomarker discovery and applications in liquid biopsy

Written byTagomics
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced the publication of a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics’ ActivaceTM platform. The paper, titled ‘Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment’, built on research from the University of Birmingham, describes Tagomics’ enzymatic approach to epigenomic profiling that targets unmethylated DNA for enrichment, and its application to biomarker identification and disease profiling in colorectal cancer patients.

Current gold standard approaches for assessing genome-wide DNA methylation levels are poorly suited to the challenge of working in liquid biopsy (blood) samples, limiting the performance of cell-free DNA based diagnostic tests. Addressing these limitations, the paper describes Active-Seq (Azide Click Tagging for In Vitro Epigenomic sequencing), a base conversion-free methodology that does not alter the underlying DNA sequence and provides a scalable and comprehensive solution for the discovery of novel biomarkers in liquid biopsy samples. Activace, built on the Active-Seq technology, is a streamlined workflow that incorporates sequencing library preparation with enrichment of unmethylated DNA. The workflow is compatible with low DNA input quantities, down to one nanogram, and has been optimised for the analysis of DNA methylation in cfDNA derived from liquid biopsy samples.

The published paper demonstrates application of Active-Seq for the detection of abnormal DNA methylation signals in a cohort of colorectal cancer patients, identifying thousands of hypomethylated and hypermethylated regions in tumour-derived tissue, both of which are associated with cancer. The study lays the groundwork for application of the approach to the deconvolution of the tissue of origin of cell-free DNA in blood, improving detection and characterisation of disease.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel